Aller au contenu principal
2023 conference-abstract

S1668 The Effects of Gastric Emptying on Weight Loss After Intragastric Balloon and Endoscopic Sleeve Gastroplasty

0Citations signalées, ce qui n’est pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Introduction: Intragastric balloon (IGB) and endoscopic sleeve gastroplasty (ESG) are endoscopic bariatric therapies (EBTs) associated with weight loss and improvement in metabolic comorbidities. Delayed gastric emptying (GE) has been associated with greater weight loss after EBT. However, data utilizing GE to predict weight loss after EBT is limited. Methods: Retrospective chart review was conducted on patients evaluated for EBT from 2016-2022 at a single urban facility. Patients with prior bariatric surgery were excluded. All patients participated in a weight loss program with a dietitian, psychologist, and bariatric endoscopist. Univariate linear regression analyses controlling for age, sex, semaglutide use, and GE rates were performed to identify predictors of % body mass index (BMI) change, % total body weight loss (TBWL) and % excess weight loss (EWL) at 6, 12, and 24 months after EBT (Ha: P< 0.05). Results: Fifty-eight patients underwent outpatient IGB or ESG and had at least 24 months of follow-up data (IGB, n=40; ESG, n=18). Average BMI at T0 was 38.5±4.7 kg/m2 with no difference in age, sex, or baseline BMI between the IGB and ESG cohorts. 23% of patients were trialed on semaglutide. Thirty-two patients (IGB, n=21; ESG, n=11) underwent GE scintigraphy prior to EBT. On univariate testing, GE at 30 minutes negatively predicted %TBWL (t= -3.7, P=0.014) and %EWL (t= -2.8, P=0.038) at six months. GE at 60 minutes positively predicted % TBWL (t=2.2, P=0.047) at 6 months, and GE at 120 minutes positively predicted %TBWL (t=2.2, P=0.046) and %EWL (t=2.6, P=0.022) at 12 months. Neither GE half time nor GE at 240 minutes predicted weight loss outcomes at 6 or 12 months. GE rates also did not predict weight loss at 24 months. In a subgroup analysis of IGB patients, GE at 30 minutes negatively predicted % TBWL (t= -3.9, P=0.03) and % EWL (t= -3.7, P=0.034) at six months. Rate of GE did not predict balloon intolerance or early removal. Among ESG patients, GE at 120 minutes positively predicted % BMI change at 6 months (t=2.9, P=0.043), and GE at 240 minutes positively predicted both % BMI change at 6 months (t=8.2, P=0.004) and 12 months (t=109.2, P=0.006). Conclusion: For all EBT patients, faster GE at 120 minutes predicted greater weight loss at 12 months. Interestingly, slower GE at 30 minutes was associated with greater weight loss at 6 months for IGB patients, but not with weight loss at 12 or 24 months. These patient factors can inform weight loss outcomes and guide pre-procedural counseling (Table 1). Table 1. - Univariate linear regression analyses associated with excess weight loss (EWL) and total body weight loss (TBWL) at six and twelve months after endoscopic bariatric therapy (including intragastric balloon (IGB) or endoscopic sleeve gastroplasty (ESG)) % TBWL (6 months) % EWL (6 months) % TBWL (12 months) % EWL (12 months) Gastric emptying t value 95% CI p value t value 95% CI p value t value 95%CI p value t value 95%CI p value 30 minutes -3.7 -34.5 – -6.1 0.014* -2.8 -107.2 – -4.7 0.038* -2.7 -44.1 –-0.7 0.055 -2.5 -134.5 – 8.5 0.071 60 minutes 2.2 0.2 – 26.2 0.047* 1.6 -9.9 – 73.2 0.124 1.9 -2.5 – 32.7 0.085 1.8 -9.2 – 94.1 0.098 120 minutes 0.96 -7.9 – 21.1 0.353 0.4 -40.6 – 56.8 0.730 2.2 0.4 – 35.9 0.046* 2.6 10.5 – 116.1 0.022* 240 minutes 1.1 -30.2 – 93.6 0.29 0.2 -186.0 – 224.3 0.844 1.7 -15.8 – 131.9 0.112 1.8 -34.7 – 404.5 0.092 All analyses are controlled for age, sex, and semaglutide use. GE at 30 minutes negatively predicted % TBWL (t= -3.7, P=0.014) and %EWL (t= -2.8, P=0.038) at six months. GE at 60 minutes positively predicted % TBWL (t=2.2, P=0.047) at six months, while GE at 120 minutes positively predicted % TBWL (t=2.2, P=0.046) and % EWL (t=2.6, P=0.022) at 12 months.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
S1668 The Effects of Gastric Emptying on Weight Loss After Intragastric Balloon and Endoscopic Sleeve Gastroplasty
Date Crossref
01/10/2023
Éditeur
Ovid Technologies (Wolters Kluwer Health)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Bariatric Surgery and Outcomes

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.